Remdesivir No Longer Recommended And Pfizer Stepping Closer To Vaccine Approval

0

The CDC is saying the anti-viral drug Remdesivir is no longer recommended for hospitalized patients suffering from the effects of the COVID-19 virus. Saying that the drug is simply no evidence that the drug improves survival nor reduces the need for ventilation.

Pfizer is one step closer to applying for emergency authorization for its vaccine against COVID-19. When can they expect approval and how soon they could begin distribution all in the video.